NATAN DAVID 4
4 · TITAN PHARMACEUTICALS INC · Filed Oct 26, 2023
Insider Transaction Report
Form 4
NATAN DAVID
Director
Transactions
- Award
Common Stock
2023-10-25+16,250→ 66,250 total
Footnotes (1)
- [F1]The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant.